Paper40189720
The potential of miR-29 in modulating tumor angiogenesis: a comprehensive review.
Zhou RT and 4 others. Discov Oncol, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. The potential of miR-29 in modulating tumor angiogenesis: a comprehensive review. Papers, record 40189720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40189720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81670555 | National Natural Science Foundation of China | PubMed | ||
| 2060204 | State Key Laboratory Special Fund | PubMed | ||
| 2022KZL2-07 | The Opening Foundation of Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy | PubMed |
Source PubMed
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27356624 | Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas. | Sci Rep | 2016 | https://conductscience.org/library/papers/27356624 | PubMed |
| 2 | 31382461 | Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis. | J Clin Med | 2019 | https://conductscience.org/library/papers/31382461 | PubMed |
| 3 | 23113351 | The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression. | Mol Biol (Mosk) | 2012 | https://conductscience.org/library/papers/23113351 | PubMed |
| 4 | 28633655 | Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28633655 | PubMed |
| 5 | 31205560 | Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF-1α Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells. | J Cancer | 2019 | https://conductscience.org/library/papers/31205560 | PubMed |
| 6 | 18559520 | Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer. | Cancer Res | 2008 | https://conductscience.org/library/papers/18559520 | PubMed |
| 7 | 27826619 | Antiangiogenic cancer treatment: The great discovery and greater complexity (Review). | Int J Oncol | 2016 | https://conductscience.org/library/papers/27826619 | PubMed |
| 8 | 28345453 | Tumor suppressor miR-29c regulates radioresistance in lung cancer cells. | Tumour Biol | 2017 | https://conductscience.org/library/papers/28345453 | PubMed |
| 9 | 11586466 | Extracellular matrix degradation and the role of hepatic stellate cells. | Semin Liver Dis | 2001 | https://conductscience.org/library/papers/11586466 | PubMed |
| 10 | 25644077 | Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. | Gene | 2015 | https://conductscience.org/library/papers/25644077 | PubMed |
| 11 | 9500469 | Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. | Cancer Res | 1998 | https://conductscience.org/library/papers/9500469 | PubMed |
| 12 | 30849371 | VEGF in Signaling and Disease: Beyond Discovery and Development. | Cell | 2019 | https://conductscience.org/library/papers/30849371 | PubMed |
| 13 | 17957028 | Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. | Blood | 2008 | https://conductscience.org/library/papers/17957028 | PubMed |
| 14 | 21793034 | MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. | Hepatology | 2011 | https://conductscience.org/library/papers/21793034 | PubMed |
| 15 | 21987025 | Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. | Ann Hematol | 2012 | https://conductscience.org/library/papers/21987025 | PubMed |
| 16 | 34470658 | The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34470658 | PubMed |
| 17 | 28368401 | circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. | Oncogene | 2017 | https://conductscience.org/library/papers/28368401 | PubMed |
| 18 | 37062273 | Downregulation of miR-210-3p Attenuates High Glucose-Induced Angiogenesis of Vascular Endothelial Cells via Targeting FGFRL1. | Ophthalmic Res | 2023 | https://conductscience.org/library/papers/37062273 | PubMed |
| 19 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 20 | 24429633 | The multilayered complexity of ceRNA crosstalk and competition. | Nature | 2014 | https://conductscience.org/library/papers/24429633 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42051962 | Comparative analysis of DNA methyltransferase 3 alpha and miR-29b expression in eutopic and ectopic endometrial tissues from endometriosis patients compared to healthy controls: A case-control study. | Int J Reprod Biomed | 2026 | https://conductscience.org/library/papers/42051962 | PubMed |
| 41868801 | miR-3921 functions as a tumor suppressor and negatively regulates RIPK1 in gastric cancer. | PeerJ | 2026 | https://conductscience.org/library/papers/41868801 | PubMed |
| 41226828 | MicroRNAs as Emerging Therapeutic Targets Modulating the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226828 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40189720
GET https://conductscience.org/api/papers/v1/40189720/references?page=2